IP Library Granted Patent US 9,636,436
Granted Patent B2
US 9,636,436 · App. 14/776,565 · Granted May 2, 2017

Compositions of and methods for cancellous bone matrix

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,436
App. No.
14/776,565
Granted
May 2, 2017
Kind
B2
Abstract

A bone repair composition including a cancellous bone matrix with cortical and/or cancellous bone particles loaded therein; and a kit comprising the cancellous bone matrix and the cortical and/or cancellous bone particles.

Claims (15)

1. A method of making a monolithic bone implant composition, comprising:

hydrating a cancellous bone matrix to form a swollen cancellous bone matrix;

loading demineralized bone particles into the swollen cancellous bone matrix to form a loaded cancellous bone matrix; and

dehydrating the loaded cancellous bone matrix to form a monolithic bone implant composition comprising a cancellous bone matrix with demineralized bone particles therein.

2. The method of claim 1 , wherein the hydrating comprises a solution selected from the group consisting of water, saline, glycerol, lecithin, sucrose, and combinations thereof.

3. The method of claim 1 , wherein the demineralized bone particles comprise demineralized bone particles in a solution selected from the group consisting of water, saline, alcohol, glycerol, and combinations thereof.

4. The method of claim 1 , wherein the dehydrating comprises heating the loaded cancellous bone matrix at a temperature in a range from about 40° C. to about 75° C.

5. The method of claim 1 , wherein the dehydrating comprises applying a vacuum or reduced pressure and/or heating to the loaded cancellous bone matrix.

6. The method of claim 1 , wherein the demineralized bone particles comprise ethanol.

7. The method of claim 1 , further comprising loading a hypotonic solution into the loaded cancellous bone matrix to swell the demineralized bone particles.

8. The method of claim 1 , further comprising loading an additive into the swollen cancellous bone matrix.

9. The method of claim 1 , wherein the demineralized bone particles comprise an additive.

10. The method of claim 9 , wherein the additive is selected from the group consisting of bone marrow cells, mesenchymal stem cells, oxygenating materials, growth factors, antibiotics, anti-neoplastic agents, and combinations thereof.

11. The method of claim 1 , wherein the hydrating comprises rehydrating a dehydrated cancellous bone matrix.

12. A monolithic bone implant composition made by the method of claim 1 .

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2025
From: THERACELL, LLC
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.
Reel/Frame 072388/0197 →
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
CHANGE OF NAME Recorded Oct 11, 2023
From: THERACELL, INC.
To: THERACELL, LLC
Reel/Frame 065219/0102 →
SECURITY INTEREST Recorded Apr 4, 2022
From: THERACELL, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 059486/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2017
From: CARTER, ANDREW J.; SCARBOROUGH, NELSON L.; PATT, BRADLEY E.
To: THERACELL, INC.
Reel/Frame 041769/0982 →